Unicycive Therapeutics In... (UNCY)
Unicycive Therapeutics Statistics
Share Statistics
Unicycive Therapeutics has 120.63M shares outstanding. The number of shares has increased by 176% in one year.
| 120.63M |
| 176% |
| 0% |
| 69.37% |
| n/a |
| 18,571 |
| 1.48% |
Short Selling Information
The latest short interest is 666.1K, so 0.55% of the outstanding shares have been sold short.
| 666.1K |
| 0.55% |
| 0.58% |
| 1 |
Valuation Ratios
The PE ratio is -14.48 and the forward PE ratio is 0.75. Unicycive Therapeutics's PEG ratio is 0.15.
| -14.48 |
| 0.75 |
| 0 |
| 0.2 |
| 71.59 |
| -18.57 |
| 0.15 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Unicycive Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.1.
| 1.28 |
| 1.28 |
| 0.1 |
| -0.02 |
| -0.03 |
| -452.35 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,669,500 |
| 22 |
| 0 |
| n/a |
Taxes
| -1.09M |
| 2.89% |
Stock Price Statistics
The stock price has increased by -1.3% in the last 52 weeks. The beta is 2, so Unicycive Therapeutics's price volatility has been higher than the market average.
| 2 |
| -1.3% |
| 0.6 |
| 0.56 |
| 69.52 |
| 1,254,134 |
Balance Sheet
The company has 26.14M in cash and 773K in debt, giving a net cash position of 25.37M.
| 26.14M |
| 773K |
| 25.37M |
| -101.27M |
| 27.95M |
| 10.67M |
Cash Flow
In the last 12 months, operating cash flow was -28.57M and capital expenditures -72K, giving a free cash flow of -28.65M.
| -28.57M |
| -72K |
| -28.65M |
| -0.04 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
UNCY does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for UNCY is $6, which is 689.5% higher than the current price. The consensus rating is "Buy".
| $6 |
| 689.5% |
| Buy |
| 3 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -6.86 |
| 3 |